BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2103829)

  • 1. A study of the action of immunosuppressive factors from tumour cells on lymphocytes and macrophages in vitro and on the graft-versus-host reaction in mice.
    Medvedev AE; Fuchs BB; Rakhmilevich AL
    Biomed Sci; 1990 Mar; 1(3):261-6. PubMed ID: 2103829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity in graft-versus-host reaction. II. Lysis of target cells of parental genotyppe by F1 hybrid macrophages.
    Fung KY; Sabbadini E
    Transplantation; 1976 Nov; 22(5):449-54. PubMed ID: 11578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of prodigiosin and its combination with immunodepressants on the graft versus host reaction in mice].
    Alekhin EK; Shigaev NI
    Antibiotiki; 1983 Nov; 28(11):842-5. PubMed ID: 6651274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulating effect on cellular immunity of the NSF17 factor produced by murine neonatal spleen cells fused with BW 5147 thymoma cells.
    Bubak-Satora M; Machala O; Kubera M; Mazur-Kolecka B; Skowron-Cendrzak A
    Folia Biol (Krakow); 1992; 40(1-2):79-82. PubMed ID: 1451838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xid mouse lymphocytes respond to TI-2 antigens when co-stimulated by TI-1 antigens or lymphokines.
    Couderc J; Février M; Duquenne C; Sourbier P; Liacopoulos P
    Immunology; 1987 May; 61(1):71-6. PubMed ID: 3294578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of antimacrophage serum on the graft vs. host reaction in F1 hybrid mice].
    Kenarova B
    Eksp Med Morfol; 1979; 18(4):216-9. PubMed ID: 42526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.
    Mowat AM; Ferguson A
    Gastroenterology; 1982 Aug; 83(2):417-23. PubMed ID: 6979490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    Fowler DH; Kurasawa K; Husebekk A; Cohen PA; Gress RE
    J Immunol; 1994 Feb; 152(3):1004-13. PubMed ID: 7905495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis.
    Piguet PF; Grau GE; Collart MA; Vassalli P; Kapanci Y
    Lab Invest; 1989 Jul; 61(1):37-45. PubMed ID: 2747216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of local and systemic GVHR by supernatants from human choriocarcinoma cell lines.
    Krishnan L; Kinsky R; Chaouat G; Talwar GP; Raghupathy R
    Cell Immunol; 1993 Sep; 150(2):376-81. PubMed ID: 8370079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.
    Hasday JD; Shah EM; Lieberman AP
    J Immunol; 1990 Jul; 145(1):371-9. PubMed ID: 2358679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of a nonprotein spleen factor on the course of delayed-type hypersensitivity and graft versus host reactions].
    Bykova LM; Synel'nykova HL; Oliĭnyk BV
    Fiziol Zh (1994); 2001; 47(5):74-6. PubMed ID: 11758472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.